Asset Publisher

Back Delivery of Time and Temperature-Sensitive Compassionate Use Therapies in the Time of COVID-19

Delivery of Time and Temperature-Sensitive Compassionate Use Therapies in the Time of COVID-19 | Clinical Trial & Cold Chain Logistics

QuickSTAT delivered a therapy for a rare bone disease from the US to Thailand during COVID-19.
The medicine had to be kept at 2-8 degrees Celsius and 90% of international passenger flights were grounded.
QuickSTAT worked with the drug sponsor and hospital to ensure the medicine was delivered on time and within the temperature range.


A patient in Thailand with a rare bone disease needed access to a compassionate use therapy that was not yet commercially available in the country. The drug therapy also had to be kept at refrigerated temperatures of 2º to 8ºC as it traveled from the manufacturer’s facility in the U.S. to the hospital in Thailand, also taking into account time to clear customs. An already time-sensitive project, the shipment was made more complicated by the fact that stay-at-home measures due to COVID-19 had grounded 90% of international passenger flights.


QuickSTAT worked directly with the drug sponsor company in the U.S. and the hospital in Thailand to ensure the fastest delivery possible. This involved:

  • Providing a conditioned 2º to 8ºC Phase Change Material (PCM) shipper designed specifically for refrigerated products
  • Identifying the most viable route given the circumstances so the therapy would reach its destination as quickly as possible
  • Ensuring all regulatory paperwork was in order to support a seamless customs clearance process
  • Monitoring temperatures from the point of collection through to the final delivery
  • Ongoing communication, informing all parties involved of key milestones throughout the shipment's journey until it arrived at the hospital


  • The patient received the life-altering therapy on time and within the appropriate temperature range to ensure efficacy.